menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

NAFLD/NASH: Updates & Treatment Options

close
NAFLD/NASH: Updates & Treatment Options
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    Nonalcoholic fatty liver disease and steatohepatitis are well-recognized clinical concerns. What are we learning from the latest research? What is the diagnostic value of liver biopsy? Dr. Naga Chalasani, professor of medicine in the division of gastroenterology and hepatology at Indiana University School of Medicine, also examines the manifestation and risk profile of each disease with host Dr. Jay Goldstein. How do statins factor into current treatment patterns?

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Nonalcoholic fatty liver disease and steatohepatitis are well-recognized clinical concerns. What are we learning from the latest research? What is the diagnostic value of liver biopsy? Dr. Naga Chalasani, professor of medicine in the division of gastroenterology and hepatology at Indiana University School of Medicine, also examines the manifestation and risk profile of each disease with host Dr. Jay Goldstein. How do statins factor into current treatment patterns?

Facebook Comments

Programs 5/18/21